Cannabis Market Bullish Sentiment Shift
Cannabis stocks did experience a significant surge, with regulatory breakthroughs including DOJ rescheduling of marijuana as a less-dangerous drug, and psychedelic stocks also rallying following Trump executive action. However, the specific catalyst in the prediction — Trump endorsing CBD for senior healthcare on Truth Social — is not directly evidenced in the articles, though the broader bullish sentiment shift in cannabis markets did materialize. The prediction's core thesis of regulatory changes and market enthusiasm is supported, even if the exact trigger differed.
Cannabis and CBD stocks fail to see increased trading volume, investment, or M&A activity in the six months following the endorsement, or regulatory stance on CBD/cannabis shows no movement.